These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The addition of buspirone to SSRI in the treatment of adolescent obsessive-compulsive disorder. A study of six cases. Thomsen PH; Mikkelsen HU Eur Child Adolesc Psychiatry; 1999 Jun; 8(2):143-8. PubMed ID: 10435463 [No Abstract] [Full Text] [Related]
24. Placebo-controlled trial of fluoxetine and phenelzine for obsessive-compulsive disorder. Jenike MA; Baer L; Minichiello WE; Rauch SL; Buttolph ML Am J Psychiatry; 1997 Sep; 154(9):1261-4. PubMed ID: 9286186 [TBL] [Abstract][Full Text] [Related]
25. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder. Pigott TA; Seay SM J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636 [TBL] [Abstract][Full Text] [Related]
26. On the pharmacotherapy of obsessive-compulsive disorder: is a consensus possible? Todorov C; Freeston MH; Borgeat F Can J Psychiatry; 2000 Apr; 45(3):257-62. PubMed ID: 10779882 [TBL] [Abstract][Full Text] [Related]
27. Clonazepam as an augmenting agent in the treatment of childhood-onset obsessive-compulsive disorder. Leonard HL; Topol D; Bukstein O; Hindmarsh D; Allen AJ; Swedo SE J Am Acad Child Adolesc Psychiatry; 1994; 33(6):792-4. PubMed ID: 8083135 [TBL] [Abstract][Full Text] [Related]
28. Double-blind comparison of fluoxetine versus clomipramine in the treatment of obsessive compulsive disorder. López-Ibor JJ; Saiz J; Cottraux J; Note I; Viñas R; Bourgeois M; Hernández M; Gómez-Pérez JC Eur Neuropsychopharmacol; 1996 May; 6(2):111-8. PubMed ID: 8791036 [TBL] [Abstract][Full Text] [Related]
29. Rapid remission of OCD with tramadol hydrochloride. Goldsmith TB; Shapira NA; Keck PE Am J Psychiatry; 1999 Apr; 156(4):660-1. PubMed ID: 10200754 [No Abstract] [Full Text] [Related]
30. Fluoxetine in children and adolescents with OCD: a placebo-controlled trial. Liebowitz MR; Turner SM; Piacentini J; Beidel DC; Clarvit SR; Davies SO; Graae F; Jaffer M; Lin SH; Sallee FR; Schmidt AB; Simpson HB J Am Acad Child Adolesc Psychiatry; 2002 Dec; 41(12):1431-8. PubMed ID: 12447029 [TBL] [Abstract][Full Text] [Related]
31. Sertraline-induced enuresis in a prepubertal child resolves after switching to fluoxetine. Maalouf FT; Gilbert AR J Child Adolesc Psychopharmacol; 2010 Apr; 20(2):161-2. PubMed ID: 20415614 [No Abstract] [Full Text] [Related]
33. Side effects as predictors of drug response in obsessive-compulsive disorder. Ackerman DL; Greenland S; Bystritsky A J Clin Psychopharmacol; 1999 Oct; 19(5):459-65. PubMed ID: 10505588 [TBL] [Abstract][Full Text] [Related]
35. Urinary Retention in an Adolescent Patient Caused by Fluoxetine Alone. Karadag M; Gokcen C; Bayar H; Aksoy I J Child Adolesc Psychopharmacol; 2015 Oct; 25(8):658. PubMed ID: 26485088 [No Abstract] [Full Text] [Related]
36. Patients with obsessive-compulsive disorder (OCD) displayed cognitive deficits consistent with a dysfunction of the dorsolateral-striatal circuit. Fontenelle LF; Mendlowicz MV; Versiani M Psychol Med; 2004 Oct; 34(7):1367-8; author reply 1368-9. PubMed ID: 15697063 [No Abstract] [Full Text] [Related]
37. [Compulsive-obsessive disorder after severe head trauma: diagnosis and treatment]. Stengler-Wenzke K; Müller U; Matthes-von-Cramon G Psychiatr Prax; 2003 Jan; 30(1):37-9. PubMed ID: 12524581 [TBL] [Abstract][Full Text] [Related]
38. Clomipramine-resistant, fluoxetine-responsive obsessive compulsive disorder: a case report. Paholpak S J Med Assoc Thai; 2002 Oct; 85(10):1135-8. PubMed ID: 12501907 [TBL] [Abstract][Full Text] [Related]
39. Plasma melatonin and cortisol circadian patterns in patients with obsessive-compulsive disorder before and after fluoxetine treatment. Monteleone P; Catapano F; Tortorella A; Di Martino S; Maj M Psychoneuroendocrinology; 1995; 20(7):763-70. PubMed ID: 8848522 [TBL] [Abstract][Full Text] [Related]